Virtual Library

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

Filter Results:

Show Only Available Presentations

  • +

    P1.11 - Poster Session 1 - NSCLC Novel Therapies

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 45
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.11-021 - First-line erlotinib versus cisplatin/gemcitabine (GP) in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC): interim analyses from the phase 3, open-label, ENSURE study

      09:30 - 09:30  |  Author(s): Y. Wu

      • Abstract

      Loading...

  • +

    P1.12 - Poster Session 1 - NSCLC Early Stage

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 23
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.12-008 - The effects of different preoperative brain survey strategy on the pathological stage I non-small cell lung cancer patients

      09:30 - 09:30  |  Author(s): C. Tu

      • Abstract

      Loading...

  • +

    P2.05 - Poster Session 2 - Preclinical Models of Therapeutics/Imaging

    • Type: Poster Session
    • Track: Biology
    • Presentations: 27
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.05-019 - Therapeutic efficacy of DNA vaccine by targeting the mutant Kras in KrasG12D-induced lung cancer model

      09:30 - 09:30  |  Author(s): M. Yen

      • Abstract

      Loading...

  • +

    P2.10 - Poster Session 2 - Chemotherapy

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 52
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.10-049 - Lung and Bone Metastasis Are Associated With Different Response and Disease Control Rate of First-line Therapy in Patients With Adenocarcinoma of Lung.

      09:30 - 09:30  |  Author(s): C. Wu

      • Abstract

      Loading...

  • +

    P2.11 - Poster Session 2 - NSCLC Novel Therapies

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 46
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.11-036 - Association Between Tumor EGFR Mutation and primary tumor location in Patients with Adenocarcinoma of the Lungs

      09:30 - 09:30  |  Author(s): C. Huang

      • Abstract

      Loading...

  • +

    MO12 - Prognostic and Predictive Biomarkers III

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 12
    • Moderators:B. Han
    • Coordinates: 10/29/2013, 10:30 - 12:00, Parkside Ballroom B, Level 1
    • +

      MO12.03 - Biomarker analysis of a randomized, controlled, multicenter clinical trial comparing pemetrexed/cisplatin and gmcitabine/cisplatin as first-line treatment for advanced nonsquamous non-small cell lung cancer

      10:40 - 10:45  |  Author(s): L. Zhang

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P3.07 - Poster Session 3 - Surgery

    • Type: Poster Session
    • Track: Surgery
    • Presentations: 48
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.07-013 - Chylothorax Complicating Video-assisted Thoracoscopic Pulmonary Resection in Non-small Cell Lung Cancer

      09:30 - 09:30  |  Author(s): C. Liu

      • Abstract

      Loading...

  • +

    P3.10 - Poster Session 3 - Chemotherapy

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 55
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.10-013 - Open-label, randomized multicentre, phase II trial of Oral vinorelbine (NVBo) or intravenous vinorelbine (NVBiv) with cisplatin (CDDP) in patients (pts) with advanced Non Small Cell Lung Cancer (NSCLC): A Chinese experience (CA225 study)

      09:30 - 09:30  |  Author(s): L. Zhang

      • Abstract

      Loading...

    • +

      P3.10-044 - Overall Survival analysis results of TFINE Study (CTONG 0904): Different Dose Docetaxel plus Cisplatin as First-line Chemotherapy and Then Maintenance Therapy with Single Agent Docetaxel for Advanced non-Small Cell Lung Cancer

      09:30 - 09:30  |  Author(s): S. Lu

      • Abstract

      Loading...

  • +

    P3.11 - Poster Session 3 - NSCLC Novel Therapies

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 52
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.11-033 - Brain Metastasis Features and Association with Tumor EGFR mutation in Patients with Adenocarcinoma of the Lungs

      09:30 - 09:30  |  Author(s): Y. Luo

      • Abstract

      Loading...

  • +

    P3.12 - Poster Session 3 - NSCLC Early Stage

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 25
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.12-025 - Survival in octogenarians with pathological stage I non-small cell lung cancer patients underwent complete resection

      09:30 - 09:30  |  Author(s): Y. Yu

      • Abstract

      Loading...